Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cusan

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
L'Union Medicale Du Canada|April 1, 1980
[Inhibition of testicular steroidogenesis in the rat following administration of an LHRH agonist]A Bélanger, L Cusan, C Séguin, et al.
Biology of Reproduction|April 1, 1981
Ovarian progestins, androgens and estrogen throughout the 4-day estrous cycle in the ratA Bélanger, L Cusan, S Caron, et al.
Journal of Reproduction and Fertility|July 1, 1982
Rat sperm enzymes during epididymal transitK Purvis, L Cusan, H Attramadal, et al.
Journal of Steroid Biochemistry|December 1, 1987
Effects of flutamide and aminoglutethimide on plasma 5 alpha-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostateM Brochu, A Bélanger, A Dupont, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1988
Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinomaA Bélanger, F Labrie, A Dupont, et al.
Journal of Steroid Biochemistry|October 1, 1987
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancerC Labrie, L Cusan, M Plante, et al.
The Journal of Urology|September 1, 1993
Response to flutamide withdrawal in advanced prostate cancer in progression under combination therapyA Dupont, J L Gomez, L Cusan, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1993
Major advantages of "early" administration of endocrine combination therapy in advanced prostate cancerF Labrie, A Dupont, L Cusan, et al.
The Journal of Endocrinology|September 1, 1996
Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal womenP Diamond, L Cusan, J L Gomez, et al.
Life Sciences|October 1, 1977
Extremely rapid degradation of [3H] methionine-enkephalin by various rat tissues in vivo and in vitroA Dupont, L Cusan, M Garon, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
L'Union Medicale Du Canada|April 1, 1980
[Inhibition of testicular steroidogenesis in the rat following administration of an LHRH agonist]A Bélanger, L Cusan, C Séguin, et al.
Biology of Reproduction|April 1, 1981
Ovarian progestins, androgens and estrogen throughout the 4-day estrous cycle in the ratA Bélanger, L Cusan, S Caron, et al.
Journal of Reproduction and Fertility|July 1, 1982
Rat sperm enzymes during epididymal transitK Purvis, L Cusan, H Attramadal, et al.
Journal of Steroid Biochemistry|December 1, 1987
Effects of flutamide and aminoglutethimide on plasma 5 alpha-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostateM Brochu, A Bélanger, A Dupont, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1988
Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinomaA Bélanger, F Labrie, A Dupont, et al.
Journal of Steroid Biochemistry|October 1, 1987
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancerC Labrie, L Cusan, M Plante, et al.
The Journal of Urology|September 1, 1993
Response to flutamide withdrawal in advanced prostate cancer in progression under combination therapyA Dupont, J L Gomez, L Cusan, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1993
Major advantages of "early" administration of endocrine combination therapy in advanced prostate cancerF Labrie, A Dupont, L Cusan, et al.
The Journal of Endocrinology|September 1, 1996
Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal womenP Diamond, L Cusan, J L Gomez, et al.
Life Sciences|October 1, 1977
Extremely rapid degradation of [3H] methionine-enkephalin by various rat tissues in vivo and in vitroA Dupont, L Cusan, M Garon, et al.
Pageof 10